3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Pain
9
Cancer Pain
5
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Agnosia
3
Rectal Neoplasms
2
Chronic Pain
2
Breakthrough Pain
2
post laminectomy syndrome
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Terminal Cancer
1
Prostatic Neoplasms
1
Postoperative Cognitive Complications
1
Polyps
1
Pleural Effusion, Malignant
1
Patient Satisfaction
1
Pain, Postoperative
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Ileus
1
Failed Back Surgery Syndrome
1
Emergencies
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Constipation
1
Arrhythmias, Cardiac
1
Interventions
Propofol
6
Carboplatin
5
Sevoflurane
4
Saline Solution
3
Paclitaxel
3
Nivolumab
3
Erlotinib Hydrochloride
3
Acetaminophen
3
Pemetrexed
2
Midazolam
2
Lidocaine
2
Isoflurane
2
Docetaxel
2
Desflurane
2
Cryotherapy
2
Bupivacaine
2
Bronchoscopy
2
Anesthesia, Inhalation
2
trametinib
1
sotorasib
1
pegfilgrastim
1
icotinib
1
endostar protein
1
durvalumab
1
dabrafenib
1
capmatinib
1
camrelizumab
1
beta Carotene
1
atezolizumab
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lung Neoplasms
×
Fentanyl
×
Clear all
NCT02359175
2023-06-27
SEAVATS
Odense University Hospital
Phase 4
Completed
161 enrolled